Title : ATM Expression as a Prognostic Marker in Patients With Advanced Biliary Tract Cancer Treated With First-line Gemcitabine and Platinum Chemotherapy.

Pub. Date : 2021 Jan-Feb

PMID : 33402502






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ATM Expression as a Prognostic Marker in Patients With Advanced Biliary Tract Cancer Treated With First-line Gemcitabine and Platinum Chemotherapy. Platinum ATM serine/threonine kinase Homo sapiens
2 In a subgroup analysis, EH-CCC patients with ATM loss tended to have improved PFS after platinum-based chemotherapy compared to those with intact ATM (7.9 vs. 6.2 months, respectively; p=0.050). Platinum ATM serine/threonine kinase Homo sapiens
3 CONCLUSION: We demonstrated that ATM loss could be a prognostic marker after platinum-based chemotherapy in patients with advanced EH-CCC. Platinum ATM serine/threonine kinase Homo sapiens